SQUAMOUS CELL CARCINOMA OF THE OROPHARYNX
Clinical trials for SQUAMOUS CELL CARCINOMA OF THE OROPHARYNX explained in plain language.
Never miss a new study
Get alerted when new SQUAMOUS CELL CARCINOMA OF THE OROPHARYNX trials appear
Sign up with your email to follow new studies for SQUAMOUS CELL CARCINOMA OF THE OROPHARYNX, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental drug aims to shrink head and neck cancers before surgery
Disease control OngoingThis study tests an oral drug called APG-157 in 24 people with newly diagnosed head and neck cancer. The goal is to see if taking the drug before standard treatments like surgery can shrink tumors and improve outcomes. Researchers will measure tumor size changes using scans and c…
Matched conditions: SQUAMOUS CELL CARCINOMA OF THE OROPHARYNX
Phase: PHASE2 • Sponsor: Aveta Biomics, Inc. • Aim: Disease control
Last updated May 17, 2026 03:29 UTC
-
Surgical sleuthing: tongue tissue removal may unmask hidden cancers
Knowledge-focused OngoingThis study looks at a new surgical method to find the original site of head and neck cancers that have spread to lymph nodes but have no known starting point. About 100 patients will have their tongue base tissue removed and examined in detail. The goal is to see if this approach…
Matched conditions: SQUAMOUS CELL CARCINOMA OF THE OROPHARYNX
Sponsor: Royal Marsden NHS Foundation Trust • Aim: Knowledge-focused
Last updated May 06, 2026 16:03 UTC